Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy

Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic Nephropathy Brief Summary:This clinical trial assessed the safety of human umbilical cord mesenchymal stem cell therapy in 15 patients with diabetic nephropathy. Fifteen subjects received umbilical cord mesenchymal stem cell therapy 3 times. Approximately 1 × 106/kg of human umbilical cord mesenchymal stem cells 阅读更多…

العلاج بالخلايا الجذعية

لعلاج باستخدام الخلايا الجذعية هو زراعة خلايا بشرية أو حيوانية لتعويض الخلايا أو الأنسجة التالفة في محاولة لعلاج الأمراض. قد يستخدم العلاج الخلوي والعلاج الجيني معا للوصول لأفضل النتائج. أي استخدام الخلايا الجذعية للعلاج أو الوقاية من مرض أو حالة معينة.

Stem cell-based implants successfully secrete insulin in patients with type 1 糖尿病

Stem cell-based implants successfully secrete insulin in patients with type 1 diabetesDate:December 2, 2021来源:Cell PressSummary:Interim results from a multicenter clinical trial demonstrate insulin secretion from engrafted cells in patients with type 1 糖尿病. The safety, tolerability, and efficacy of the implants, which consisted of pancreatic endoderm cells derived from human 阅读更多…

乌克兰的干细胞治疗

Short List of Commonly Used Acronyms in Clinical Research

  Short List of Commonly Used Acronyms in Clinical Research 700U Statement of Economic Interest ACRP Association of Clinical Research Professionals AE Adverse Event ADR Adverse Drug Reaction AMA American Medical Association BID Twice Daily BIND BiologicalIND CAP Collegeof American Pathologists CBCTN Community Based Clinical Trials Network CBER Centerfor Biologics Evaluation and 阅读更多…

乌克兰的干细胞治疗

Юридическое обеспечение клинических и постклинических исследований лекарственных средств в контексте обеспечения прав пациента.

Асоціація правників України NBScience limited (Великобритания) Видавничий дім «Заславський» __________________________________________________________________ Уважаемые Коллеги, приглашаем Вас принять участие в круглом столе: “Юридическое обеспечение клинических и постклинических исследований лекарственных средств в контексте обеспечения прав пациента.”   Дата проведения: 08 сентября 2011 REGISTER HERE Организаторы: Ассоциация Юристов Украины, NBS科学有限公司 ( Великобритания), Основные 阅读更多…

تفاعلكم : حقيقة العلاج بالخلايا الجذعية في الصين

عبر حسابها في تويتر، حذرت سفارة السعودية في الصين مواطنيها من إدعاءات علاج بعض الأمراض المستعصية هناك. وفي بيان، أشارت السفارة إلى أن العلاج بالخلايا الجذعية ما زال في طور التجارب، ولا يوجد أي مركز معتمد للعلاج بالخلايا الجذعية في الصين حاليا. وأفادت السفارة بأن الملحقية الصحية في بكين لديها 阅读更多…

Therapeutic effect and safety of stem cell therapy for chronic liver disease: a systematic review and meta-analysis of randomized controlled trials

AbstractBackgroundStem cell therapy is becoming an emerging therapeutic option for chronic liver disease (CLD). 然而, whether stem cell therapy is more effective than conventional treatment remains questionable. We performed a large-scale meta-analysis of randomized controlled trials (RCTs) to evaluate the therapeutic effects and safety of stem cell therapy for CLD. 阅读更多…

乌克兰的干细胞治疗

Более подробно о NBScience

国家统计局科学 – это не просто исследовательская организация. Это компания, которая обьединяет сеть контрактных организаций (合同研究组织) для быстрого и эффективного выполнения клинических исследований ЛС. 9K33HJVBGPSQ В мире существует более 500 контрактных организаций. Для того, чтобы КИ выполнялись качественно, мы выбираем лучшие компании-исполнители для Спонсоров. Мы помогаем CRO и клиническим базам найти 阅读更多…

Follow-up Study After ACLSCT for Restoration of Corneal Epithelium in Patients With LSCD Due to Ocular Burns (HOLOCORE-FU)

Follow-up Study After ACLSCT for Restoration of Corneal Epithelium in Patients With LSCD Due to Ocular Burns (HOLOCORE-FU) This is a multinational, multicentre, prospective, non-pharmacological follow-up study of the clinical trial HOLOCORE. All patients transplanted with Holoclar in the HOLOCORE clinical trial who consent to participate will be enrolled in 阅读更多…

Mesenchymal stem cell therapy for liver disease: full of chances and challenges

AbstractLiver disease is a major health problem that endangers human health worldwide. 现在, whole organ allograft transplantation is the gold standard for the treatment of end-stage liver disease. A shortage of suitable organs, high costs and surgical complications limit the application of liver transplantation. Mesenchymal stem cell therapy has been 阅读更多…

Stem-cell therapy

Stemcell therapy is the use of stem cells to treat or prevent a disease or condition. As of 2016, the only established therapy using stem cells is hematopoietic stem cell transplantation. This usually takes the form of a bone-marrow transplantation, but the cells can also be derived from umbilical cord blood.

Could Stem Cell Therapy be the Cure in Liver Cirrhosis?

AbstractOver the past five decades, liver cirrhosis has become an increasingly prevalent disease and one that will often require considerable medical intervention. 然而, current treatment options have demonstrated severe problems that have prompted research to provide a suitable alternative. These treatments are scarcely available, very expensive and present at a 阅读更多…

Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells

AbstractBackground & aims: Liver transplantation is the primary treatment for various end-stage hepatic diseases but is hindered by the lack of donor organs and by complications associated with rejection and immunosuppression. There is increasing evidence to suggest the bone marrow is a transplantable source of hepatic progenitors. We previously reported 阅读更多…

干细胞疗法